MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Demystifying the Delivery of Multi-arm Multi-stage Platform Trials for Parkinson’s Disease –Framework and Recommendations from EJS ACT-PD

    C. Girges, J. Inches, L. Brennan, G. Mills, M. Zeissler, E. de Pablo-Fernandez, C. Pugh, C. Gonzalez-Robles, R. Gurney, S. Collins, C. Murphy, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To develop a framework of protocol-aligned rater training, educational resources, and inter-site engagement (Stage 1). The secondary aim was to assess the perceived usefulness…
  • 2026 International Congress

    Movement decoding from subthalamic nucleus during deep brain stimulation surgery

    J. Li, J. Olson, C. Gonzalez, C. Hurt, M. Wade, H. Walker (Birmingham, USA)

    Objective: To evaluate motor classification and somatotopy of local field potentials (LFPs) recorded from subthalamic nucleus (STN) directional deep brain stimulation (DBS) electrodes. Background: STN…
  • 2026 International Congress

    Beyond Parkinson’s Disease, Impulse Control Dysregulation: The Psychosocial Correlates of Problematic Internet Use

    T. Adeoye, O. Buhari, O. Adeoye (Ogbomoso, Nigeria)

    Objective: To determine the prevalence of problematic internet use and associated psychosocial correlates as a phenotype of impulse control dysregulation among undergraduates. Background: Impulse control…
  • 2026 International Congress

    Do Digital Mobility Outcomes Differ Across Clinically Defined NSD-ISS Stages in Parkinson’s Disease?

    P. Tait, L. Alcock, C. Schlenstedt, C. Caroll, C. Becker, J. Buekers, B. Caulfield, A. Cereatti, S. Del-Din, L. Delgado-Ortiz, J. Garcia-Aymerich, S. Koch, P. Ginis, H. Gassner, A. Nieuwboer, J. Hausdorf, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall (Newcastle upon Tyne, United Kingdom)

    Objective: To determine whether digital mobility outcomes (DMOs) differ between individuals with relatively advanced PD grouped according to the clinical criteria of the Neuronal α-Synuclein…
  • 2026 International Congress

    Risk of Ischemic Cerebrovascular Events in Patients with Deep Brain Stimulation for Parkinson’s Disease: A Cohort Study

    P. Antenucci, M. Paciaroni, A. Gozzi, A. Mechelli, M. Pugliatti, D. Gragnaniello, M. Sensi (Ferrara, Italy)

    Objective: To longitudinally assess the risk of ischemic cerebrovascular events in patients undergoing DBS Background: Longitudinal data on the potential impact of DBS on long-term…
  • 2026 International Congress

    Robot-Assisted Transplantation of Hypoimmune iPSC Derived Dopaminergic Progenitor Cells for Idiopathic Parkinson’s Disease

    J. Shi, J. Yu, C. Han, A. Chen, L. Jiao, R. Qian (Hefei, China)

    Objective: This study aimed to evaluate the 12-month safety and preliminary efficacy of NCR201 transplantation in idiopathic PD patients, providing a proof-of-concept for universal cell…
  • 2026 International Congress

    Clinical Impact of Nicotine in Parkinson’s Disease: Evidence from Randomized Controlled Studies

    J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To evaluate the effects of nicotine versus placebo in Parkinson’s disease (PD). Background: Nicotine may influence dopaminergic and non‑dopaminergic pathways relevant to PD. While…
  • 2026 International Congress

    Transcutaneous Spinal Cord Stimulation in Hereditary Spastic Paraplegias

    J. Sanderson, M. Davis, H. Farhadi, C. Moritz, F. Inanici (Seattle, USA)

    Objective: To assess transcutaneous spinal cord stimulation (tSCS) as a treatment for hereditary spastic paraplegias (HSPs). Background: Hereditary spastic paraplegias (HSPs) are genetic disorders characterized…
  • 2026 International Congress

    An artificial intelligence-based model to predict Parkinson’s disease risk: the AI-PRA study protocol.

    SV. Virameteekul, S. Hadjidimitriou, I. Gerasimou, C. Sotirakis, L. Hadjileontiadis, M. Almarcha-Menargues, B. Falkenburger, O. Sánchez-Soliño, K. Michailidou, M. Zanti, P. Chairta, K. Christodoulou, M. Kurtis, M. Fabbri, N. Del Campo, A. Noyce, E. de Pablo-Fernández (London, United Kingdom)

    Objective: To present the protocol of the Artificial Intelligence-based Parkinson’s Risk Assessment (AI-PRA) study which aims to validate a novel personalised PD risk prediction model…
  • 2026 International Congress

    Genetically proven Juvenile-Onset Niemann–Pick Disease Type C Presenting with Dystonia- Ataxia syndrome.

    A. Ranjan, A. Kumar, A. -, N. Sinha, A. Kumar, P. Anand (Patna, India)

    Objective: We present a case  Juvenile-Onset Niemann–Pick Disease Type C (NPC) who Presented to us with progressive Dystonia- Ataxia syndrome. Background: Niemann–Pick disease type C…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley